You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

DESOXIMETASONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Desoximetasone, and what generic alternatives are available?

Desoximetasone is a drug marketed by Actavis Mid Atlantic, Cosette, Fougera Pharms, Lupin, Padagis Israel, Rising, Sciegen Pharms Inc, Zydus Lifesciences, Epic Pharma Llc, Padagis Us, Altana, Glenmark Pharms Ltd, Novel Labs Inc, Pai Holdings Pharm, and The J Molner. and is included in thirty NDAs.

The generic ingredient in DESOXIMETASONE is desoximetasone. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Desoximetasone

A generic version of DESOXIMETASONE was approved as desoximetasone by PADAGIS ISRAEL on July 1st, 2003.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DESOXIMETASONE?
  • What are the global sales for DESOXIMETASONE?
  • What is Average Wholesale Price for DESOXIMETASONE?
Drug patent expirations by year for DESOXIMETASONE
Drug Prices for DESOXIMETASONE

See drug prices for DESOXIMETASONE

Drug Sales Revenue Trends for DESOXIMETASONE

See drug sales revenues for DESOXIMETASONE

Recent Clinical Trials for DESOXIMETASONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesPhase 4
Psoriasis Treatment Center of Central New JerseyPhase 4
Siriraj clinical research centerPhase 3

See all DESOXIMETASONE clinical trials

Pharmacology for DESOXIMETASONE
Medical Subject Heading (MeSH) Categories for DESOXIMETASONE
Paragraph IV (Patent) Challenges for DESOXIMETASONE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
TOPICORT Topical Spray desoximetasone 0.25% 204141 1 2013-12-18

US Patents and Regulatory Information for DESOXIMETASONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Lifesciences DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 205206-001 Sep 19, 2017 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Lupin DESOXIMETASONE desoximetasone SPRAY;TOPICAL 208124-001 Mar 16, 2018 AT RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Actavis Mid Atlantic DESOXIMETASONE desoximetasone CREAM;TOPICAL 205082-001 Sep 4, 2015 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Epic Pharma Llc DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 201005-001 Apr 24, 2014 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Padagis Israel DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 077770-001 Apr 20, 2015 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Rising DESOXIMETASONE desoximetasone CREAM;TOPICAL 210980-001 Dec 21, 2018 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

DESOXIMETASONE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Desoximetasone

Introduction to Desoximetasone

Desoximetasone is a potent topical corticosteroid used to treat various skin conditions, including eczema, psoriasis, and dermatitis. It is known for its anti-inflammatory properties and is applied directly to the skin to reduce inflammation and irritation.

Market Overview

The global market for topical corticosteroids, which includes desoximetasone, has been experiencing significant growth driven by several key factors.

Rising Prevalence of Dermatological Conditions

The increasing prevalence of skin disorders such as eczema, psoriasis, and dermatitis is a major driver of the market. As the global population grapples with these conditions, the demand for effective treatments like desoximetasone continues to rise[5].

Growing Geriatric Population

The geriatric population is more prone to skin-related issues, which has further fueled the demand for topical corticosteroids. This demographic shift is expected to continue driving market growth in the coming years[5].

Technological Advancements

Advancements in drug formulations have led to the development of more effective and safer topical corticosteroids. These innovations enhance therapeutic outcomes and patient compliance, contributing to the market's expansion[5].

Market Size and Growth Projections

The global topical corticosteroids market, which includes desoximetasone, was valued at USD 4,270.71 million in 2023 and is expected to grow to USD 6,102.07 million by 2030, at a Compounded Annual Growth Rate (CAGR) of 5.2%[5].

Key Manufacturers and Market Share

The desoximetasone market is dominated by several key manufacturers. A detailed analysis of these manufacturers includes their product specifications, production capacity, market share, and financial performance.

  • Global Key Manufacturers: Companies such as Perrigo, among others, play a significant role in the production and distribution of desoximetasone. These companies have a substantial market share and are involved in continuous research and development to improve product efficacy and safety[2][5].

Market Dynamics

Upstream Raw Materials and Downstream Clients

The production of desoximetasone involves the procurement of specific raw materials. The availability and cost of these raw materials can significantly impact the production process and overall market dynamics. Downstream clients, including hospitals, pharmacies, and retail stores, also influence the market by driving demand and affecting distribution channels[1].

Current Market Trends

The market for desoximetasone is influenced by several trends, including the increasing preference for non-invasive treatment methods and the growing demand for localized treatment options. Technological innovations in drug delivery systems are also driving the market forward[3].

Regulatory Environment

The topical corticosteroids market, including desoximetasone, is subject to strict regulatory policies. These regulations can impact the approval and distribution of new products, affecting the overall market growth. Companies must comply with these regulations to ensure the safety and efficacy of their products[5].

Financial Trajectory

Historical Market Performance

From 2009 to 2014, the global and Chinese desoximetasone market experienced significant growth, driven by increasing demand for topical corticosteroids. The market was valued based on key economic parameters such as production value, market share, and capacity of major manufacturers[1].

Future Market Projections

The market for desoximetasone is expected to continue growing, driven by the factors mentioned above. By 2030, the global topical corticosteroids market is projected to reach USD 6,102.07 million, indicating a positive financial trajectory for desoximetasone and other topical corticosteroids[5].

Export and Import Dynamics

Desoximetasone is exported and imported globally, with key countries such as India, the United States, and Italy playing significant roles in the trade.

  • Export Market Share: India accounts for the maximum share of desoximetasone exports, followed by the United States and Italy. This data is crucial for exporters and importers looking to expand their global trade and improve supply chain efficiency[4].

Challenges and Opportunities

Side Effects and Regulatory Concerns

Despite the growth potential, the market faces challenges such as concerns over the side effects of prolonged use of corticosteroids, including skin thinning and hormonal imbalances. Strict regulatory policies and high treatment costs are additional barriers to market growth[5].

Emerging Markets and Technological Advancements

Emerging markets, particularly in Asia and Latin America, offer significant opportunities for growth due to increasing disposable incomes and growing awareness about dermatological treatments. The rise of online pharmacies and advancements in telemedicine are also making these treatments more accessible[5].

Proposals for New Projects

For companies considering new projects in the desoximetasone industry, it is crucial to evaluate the feasibility based on market dynamics, regulatory environment, and technological advancements. Proposals should include detailed market analysis, production capacity planning, and strategies for compliance with regulatory requirements[1].

Conclusion

The market for desoximetasone is poised for continued growth, driven by the increasing prevalence of dermatological conditions, technological advancements, and expanding product availability. However, the market also faces challenges related to side effects and regulatory concerns. Understanding these dynamics is essential for stakeholders to make informed decisions and capitalize on emerging opportunities.

Key Takeaways

  • The global topical corticosteroids market, including desoximetasone, is expected to grow at a CAGR of 5.2% from 2023 to 2030.
  • The market is driven by the rising prevalence of dermatological conditions and technological advancements in drug formulations.
  • Key manufacturers play a significant role in the production and distribution of desoximetasone.
  • The market faces challenges such as side effects of prolonged use and strict regulatory policies.
  • Emerging markets and advancements in telemedicine offer significant opportunities for growth.

FAQs

Q: What is desoximetasone used for?

Desoximetasone is a topical corticosteroid used to treat various skin conditions, including eczema, psoriasis, and dermatitis.

Q: What drives the demand for desoximetasone?

The demand for desoximetasone is driven by the increasing prevalence of dermatological conditions, technological advancements in drug formulations, and the growing geriatric population.

Q: Which countries are major exporters of desoximetasone?

India, the United States, and Italy are among the major exporters of desoximetasone.

Q: What are the challenges faced by the desoximetasone market?

The market faces challenges such as concerns over side effects of prolonged use, strict regulatory policies, and high treatment costs.

Q: What are the growth projections for the desoximetasone market?

The global topical corticosteroids market, including desoximetasone, is expected to grow to USD 6,102.07 million by 2030 at a CAGR of 5.2%.

Sources

  1. Research and Markets: "Global and Chinese Desoximetasone Industry, 2009-2019" report.
  2. Perrigo Company plc: Annual Report 2021.
  3. Verified Market Research: "Topical Drug Delivery Market" report.
  4. Volza: "Desoximetasone Exports from World".
  5. Reanin: "Global Topical Corticosteroids Market" report.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.